In addition, we analyzed LASP1 expression in high-risk PCa (Gleason score >8 and PSA>20 ng/ml) and correlated the immunoreactive LASP1 scores with clinicopathological data, which yielded a significant correlation between cytosolic and nuclear LASP1 levels and PSA progression. This evidence concerns the gene LASP1 and posterior cortical atrophy.